Immunoglobulin E as a Biomarker in Asthma.

Creator(s)

Niharika Rath, Children's Mercy Hospital
Nikita Raje, Children's Mercy HospitalFollow
Lanny Rosenwasser

Document Type

Article

Publication Date

11-2018

Identifier

DOI: 10.1016/j.iac.2018.06.007

Abstract

Asthma is a chronic disease that affects children and adults with significant morbidity and mortality. It is multifactorial, with genetic and environmental factors affecting the overall course of the disease. Both specific and total immunoglobulin (Ig)E can be used in specific phenotypes such as allergic asthma. Using IgE as a biomarker for asthma provides a target for management and treatment. Biotherapeutics continue to emerge as important advances in asthma treatment, and their effect on IgE and its biomarker role continue to be studied.

Journal Title

Immunology and allergy clinics of North America

Volume

38

Issue

4

First Page

587

Last Page

597

MeSH Keywords

Asthma; Biomarkers; Humans; Immunoglobulin E

Keywords

Asthma; Biomarkers; Immunoglobulin E

Recommended Citation

Rath N, Raje N, Rosenwasser L. Immunoglobulin E as a Biomarker in Asthma. Immunol Allergy Clin North Am. 2018;38(4):587-597. doi:10.1016/j.iac.2018.06.007